|
Volumn 149, Issue 5, 2013, Pages 639-641
|
Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN PATCHED 1;
TRANSCRIPTION FACTOR GLI1;
VISMODEGIB;
ADULT;
ADVANCED CANCER;
ARTICLE;
BASAL CELL CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER LOCALIZATION;
CANCER RESISTANCE;
CANCER SURGERY;
CASE REPORT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
CONVALESCENCE;
DRUG EFFECT;
FULL THICKNESS SKIN GRAFT;
GOLTZ SYNDROME;
HUMAN;
HUMAN TISSUE;
MALE;
PRIORITY JOURNAL;
SKIN ULCER;
SKULL DEFECT;
TREATMENT DURATION;
TUMOR BIOPSY;
TUMOR VOLUME;
ANILIDES;
ANTINEOPLASTIC AGENTS;
BASAL CELL NEVUS SYNDROME;
DRUG RESISTANCE, NEOPLASM;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
PYRIDINES;
SCALP;
SKIN NEOPLASMS;
SKIN TRANSPLANTATION;
|
EID: 84877860000
PISSN: 21686068
EISSN: None
Source Type: Journal
DOI: 10.1001/jamadermatol.2013.30 Document Type: Article |
Times cited : (37)
|
References (5)
|